Owens & Minor, Inc.
Owens & Minor, Inc. (OMI) Stock Competitors & Peer Comparison
See (OMI) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| MCK | $827.20 | -1.07% | 102.3B | 23.95 | $34.62 | +0.38% |
| COR | $309.16 | -0.72% | 59.9B | 36.94 | $8.34 | +0.75% |
| CAH | $201.38 | -1.63% | 47B | 28.75 | $6.95 | +1.02% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $77.54 | -0.87% | 8.9B | 23.71 | $3.27 | N/A |
| PBH | $59.73 | +3.39% | 2.8B | 15.55 | $3.79 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +1.66% |
| GRDN | $38.81 | +4.98% | 2.4B | 48.15 | $0.78 | N/A |
| ACH | $3.34 | -0.60% | 251.5M | -2.46 | -$1.34 | N/A |
Stock Comparison
OMI vs MCK Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, MCK has a market cap of 102.3B. Regarding current trading prices, OMI is priced at $2.68, while MCK trades at $827.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas MCK's P/E ratio is 23.95. In terms of profitability, OMI's ROE is +7.33%, compared to MCK's ROE of -2.45%. Regarding short-term risk, OMI is more volatile compared to MCK. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check MCK's competition here
OMI vs COR Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, COR has a market cap of 59.9B. Regarding current trading prices, OMI is priced at $2.68, while COR trades at $309.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas COR's P/E ratio is 36.94. In terms of profitability, OMI's ROE is +7.33%, compared to COR's ROE of +1.01%. Regarding short-term risk, OMI is more volatile compared to COR. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check COR's competition here
OMI vs CAH Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, CAH has a market cap of 47B. Regarding current trading prices, OMI is priced at $2.68, while CAH trades at $201.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas CAH's P/E ratio is 28.75. In terms of profitability, OMI's ROE is +7.33%, compared to CAH's ROE of -0.59%. Regarding short-term risk, OMI is more volatile compared to CAH. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check CAH's competition here
OMI vs ABC Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, OMI is priced at $2.68, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas ABC's P/E ratio is 21.92. In terms of profitability, OMI's ROE is +7.33%, compared to ABC's ROE of +1.01%. Regarding short-term risk, OMI is more volatile compared to ABC. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check ABC's competition here
OMI vs HSIC Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, HSIC has a market cap of 8.9B. Regarding current trading prices, OMI is priced at $2.68, while HSIC trades at $77.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas HSIC's P/E ratio is 23.71. In terms of profitability, OMI's ROE is +7.33%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, OMI is more volatile compared to HSIC. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check HSIC's competition here
OMI vs PBH Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, PBH has a market cap of 2.8B. Regarding current trading prices, OMI is priced at $2.68, while PBH trades at $59.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas PBH's P/E ratio is 15.55. In terms of profitability, OMI's ROE is +7.33%, compared to PBH's ROE of +0.10%. Regarding short-term risk, OMI is more volatile compared to PBH. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check PBH's competition here
OMI vs PDCO Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, OMI is priced at $2.68, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas PDCO's P/E ratio is 20.48. In terms of profitability, OMI's ROE is +7.33%, compared to PDCO's ROE of +0.06%. Regarding short-term risk, OMI is more volatile compared to PDCO. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check PDCO's competition here
OMI vs GRDN Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, GRDN has a market cap of 2.4B. Regarding current trading prices, OMI is priced at $2.68, while GRDN trades at $38.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas GRDN's P/E ratio is 48.15. In terms of profitability, OMI's ROE is +7.33%, compared to GRDN's ROE of +0.28%. Regarding short-term risk, OMI is more volatile compared to GRDN. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check GRDN's competition here
OMI vs ACH Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, ACH has a market cap of 251.5M. Regarding current trading prices, OMI is priced at $2.68, while ACH trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas ACH's P/E ratio is -2.46. In terms of profitability, OMI's ROE is +7.33%, compared to ACH's ROE of +7.33%. Regarding short-term risk, OMI is more volatile compared to ACH. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check ACH's competition here
OMI vs GEG Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, GEG has a market cap of 56.6M. Regarding current trading prices, OMI is priced at $2.68, while GEG trades at $2.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas GEG's P/E ratio is -4.18. In terms of profitability, OMI's ROE is +7.33%, compared to GEG's ROE of -0.21%. Regarding short-term risk, OMI is more volatile compared to GEG. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check GEG's competition here
OMI vs HX Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, OMI is priced at $2.68, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas HX's P/E ratio is -1.84. In terms of profitability, OMI's ROE is +7.33%, compared to HX's ROE of -1.07%. Regarding short-term risk, OMI is more volatile compared to HX. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check HX's competition here
OMI vs WGRX Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, WGRX has a market cap of 9.2M. Regarding current trading prices, OMI is priced at $2.68, while WGRX trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas WGRX's P/E ratio is -0.09. In terms of profitability, OMI's ROE is +7.33%, compared to WGRX's ROE of +1417.60%. Regarding short-term risk, OMI is more volatile compared to WGRX. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check WGRX's competition here
OMI vs SNYR Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, SNYR has a market cap of 3.9M. Regarding current trading prices, OMI is priced at $2.68, while SNYR trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas SNYR's P/E ratio is -0.31. In terms of profitability, OMI's ROE is +7.33%, compared to SNYR's ROE of +0.83%. Regarding short-term risk, OMI is more volatile compared to SNYR. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check SNYR's competition here
OMI vs ZYXI Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, OMI is priced at $2.68, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, OMI's ROE is +7.33%, compared to ZYXI's ROE of -18.07%. Regarding short-term risk, OMI is more volatile compared to ZYXI. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check ZYXI's competition here
OMI vs MEHA Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, MEHA has a market cap of 743.8K. Regarding current trading prices, OMI is priced at $2.68, while MEHA trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas MEHA's P/E ratio is 10.80. In terms of profitability, OMI's ROE is +7.33%, compared to MEHA's ROE of +1.19%. Regarding short-term risk, OMI is more volatile compared to MEHA. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check MEHA's competition here
OMI vs RDGT Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, RDGT has a market cap of 478. Regarding current trading prices, OMI is priced at $2.68, while RDGT trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas RDGT's P/E ratio is -0.03. In terms of profitability, OMI's ROE is +7.33%, compared to RDGT's ROE of +0.42%. Regarding short-term risk, OMI is more volatile compared to RDGT. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check RDGT's competition here
OMI vs CVET Comparison April 2026
OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMI stands at 207.1M. In comparison, CVET has a market cap of 0. Regarding current trading prices, OMI is priced at $2.68, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMI currently has a P/E ratio of -0.47, whereas CVET's P/E ratio is -69.97. In terms of profitability, OMI's ROE is +7.33%, compared to CVET's ROE of -0.06%. Regarding short-term risk, OMI is more volatile compared to CVET. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check CVET's competition here